Growth Metrics

Eton Pharmaceuticals (ETON) Long-Term Debt Repayments (2022 - 2024)

Eton Pharmaceuticals' Long-Term Debt Repayments history spans 3 years, with the latest figure at $385000.0 for Q3 2024.

  • On a quarterly basis, Long-Term Debt Repayments changed 0.0% to $385000.0 in Q3 2024 year-over-year; TTM through Jun 2025 was $385000.0, a 75.0% decrease, with the full-year FY2024 number at $1.2 million, changed 0.0% from a year prior.
  • Long-Term Debt Repayments hit $385000.0 in Q3 2024 for Eton Pharmaceuticals, roughly flat from $385000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for ETON hit a ceiling of $385000.0 in Q1 2022 and a floor of $385000.0 in Q1 2022.
  • Historically, Long-Term Debt Repayments has averaged $385000.0 across 3 years, with a median of $385000.0 in 2022.
  • The widest YoY moves for Long-Term Debt Repayments: up 0.0% in 2024, down 0.0% in 2024.
  • Tracing ETON's Long-Term Debt Repayments over 3 years: stood at $385000.0 in 2022, then changed by 0.0% to $385000.0 in 2023, then changed by 0.0% to $385000.0 in 2024.
  • Business Quant data shows Long-Term Debt Repayments for ETON at $385000.0 in Q3 2024, $385000.0 in Q2 2024, and $385000.0 in Q1 2024.